{"id":591,"date":"2021-10-28T12:30:00","date_gmt":"2021-10-28T11:30:00","guid":{"rendered":"https:\/\/temporary.nolato.com\/mfn_news\/strong-increase-in-sales-and-profit\/"},"modified":"2021-10-28T12:30:00","modified_gmt":"2021-10-28T11:30:00","slug":"strong-increase-in-sales-and-profit","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/es\/mfn_news\/strong-increase-in-sales-and-profit\/","title":{"rendered":"Strong increase in sales and profit"},"content":{"rendered":"
\n

Third quarter of 2021 in brief:
\u2022 Sales increased to SEK 3,033 million (2,500)
\u2022 Operating profit (EBITA) rose to SEK 339 million (SEK 304 million, excl. a non-recurring item of SEK \u221217 million)
\u2022 EBITA margin of 11.2% (12.2%, excl. the non-recurring item)
\u2022 Profit after tax was SEK 257 million (211)
\u2022 Diluted earnings per share increased to SEK 0.95 (0.79)
\u2022 Cash flow after investments was SEK 116 million (SEK 82 million, excl. acquisitions)<\/p>\n

\u201cNolato delivered strong growth in sales and profit during the third quarter,\u201d said Christer Wahlquist, Nolato President and CEO. \u201cAlthough we are still feeling the effects of the pandemic, operating profit rose to its highest ever level for an individual quarter. We have an excellent financial position and aim to further strengthen our global offering.\u201d<\/p>\n

Medical Solutions sales totaled SEK 977 million (796); adjusted for currency and acquisitions, sales decreased by 4%. Operating profit (EBITA) was SEK\u00a0100\u00a0million (103), with an EBITA margin of 10.2% (12.9).<\/p>\n

\u201cVolumes have continued to be adversely affected by postponed surgical operations, while there has also been a return to more normal inventory levels by several customers in other areas as pandemic-related restrictions have been eased or removed,\u201d noted Christer Wahlquist. \u201cThe margin was adversely affected by a lower operating margin at the acquired American business, which was only included for one month last year, and high costs for the start-up of a large new IVD project.\u201d<\/p>\n

Integrated Solutions sales rose sharply to SEK 1,519 million (1,158). Adjusted for currency, sales increased by 39%. Operating profit (EBITA) grew to SEK\u00a0200\u00a0million (160) and the EBITA margin was 13.2% (13.8).<\/p>\n

\u201cVaporiser Heating Products (VHP) volumes were very high, but they are believed to have been impacted by some inventory build-up by customers. EMC sales also increased significantly, chiefly as a result of strong relative growth in automotive, as well as healthy growth in telecom,\u201d added Christer Wahlquist. \u201cWe expect fourth-quarter sales for this business area to be in line with or slightly lower than this year's third-quarter sales.\u201d<\/p>\n

Industrial Solutions sales totaled SEK 540 million (547). Adjusted for currency and acquisitions, sales decreased by 4%. Operating profit (EBITA) decreased to SEK\u00a042\u00a0million (48) and the EBITA margin to 7.8% (8.8).<\/p>\n

\u201cSupply chain disruptions, in which component shortages caused some customers to halt operations or reduce production capacity periodically, adversely affected Industrial Solutions and are expected to also impact the fourth quarter this year,\u201d said Christer Wahlquist.<\/p>\n

Overall, consolidated Group sales for the first nine months of 2021 totaled SEK 8,464 million (6,872), which, adjusted for currency and acquisitions, is a strong increase of 15%. Operating profit (EBITA) rose to SEK\u00a0983 million (814) excluding non-recurring items of SEK +50 million (-31). The EBITA margin amounted to 11.6% (11.8), excluding non-recurring items. Diluted earnings per share increased to SEK 2.88 (2.24). Cash flow after investments was SEK 533 million (SEK 694 million, excluding acquisitions). The financial position remains strong.<\/p>\n<\/div>\n

\n

Contact<\/strong><\/p>\n

\n

For further information, please contact:
Christer Wahlquist, President and CEO, +46 (0)705 804848
Per-Ola Holmstr\u00f6m, CFO, +46 (0)705 763340, per-ola.holmstrom@nolato.com<\/a><\/p>\n<\/div>\n

\n

About Us<\/strong><\/p>\n

\n

Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato\u2019s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. \u00a0<\/em>www.nolato.com\/IR<\/a><\/em><\/p>\n<\/div>\n

\n

This information is information that Nolato is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2021-10-28 13:30 CEST.<\/em><\/p>\n<\/div>\n

\n

Attachments<\/strong><\/p>\n

\n

Nolato Q3 2021 Interim Rep Eng<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Third quarter of 2021 in brief:\u2022 Sales increased to SEK 3,033 million (2,500)\u2022 Operating profit (EBITA) rose to SEK 339 million (SEK 304 million, excl. a non-recurring item of SEK \u221217 million)\u2022 EBITA margin of 11.2% (12.2%, excl. the non-recurring item)\u2022 Profit after tax was SEK 257 million (211)\u2022 Diluted earnings per share increased to… Continue reading Strong increase in sales and profit<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-591","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-report-interim-q3","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"es","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/mfn_news\/591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/es\/wp-json\/wp\/v2\/media?parent=591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}